Pregnancy Clinical Trial
Official title:
Prospective, Cluster Randomized Effectiveness Trial of Multiple Micronutrient Supplementation and Life Skills Education Provided From Preconception on Health and Nutrition Outcomes of Young, Reproductive-age Pakistani Women (15-24 Years)
Verified date | July 2021 |
Source | Aga Khan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary aims of this study are: 1) To evaluate the impact of supplementation with multiple micronutrients (MMN) from preconception and life skills education among women 15-18.9 years of age at enrolment on the prevalence of anemia in a population setting; and 2) To evaluate the impact of supplementation with MMN from preconception and life skills education among young women 15-24 years of age on the rate of low birth weight (LBW) in a population setting. Infants born to mothers enrolled in the study will be followed for 1 year. This study aims to enrol 25,400 non-pregnant young women in Matiari district. This sample size is anticipated to equate to 1456 births. Participants will be randomized by cluster to receive either MMN supplements and life skills education or the standard of care at enrolment. Clusters have been defined based on health facility catchment areas. MMN supplements will be provided twice weekly during the preconception period, once daily during the pregnancy period, and once daily until 6 months after giving birth during the postpartum period; and a package of life skills education materials will be provided bi-monthly during the preconception period. In addition to the primary outcomes, measurements will include micronutrient status, anthropometrics, birth outcomes, dietary intake and feeding practices, adherence, and indices of empowerment.
Status | Active, not recruiting |
Enrollment | 25447 |
Est. completion date | February 2022 |
Est. primary completion date | March 12, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 15 Years to 24 Years |
Eligibility | Inclusion Criteria: - Minimum age at enrolment: 15 years - Maximum age at enrolment: 23 years - Any marital status - Intend to comply with study intervention and follow up Exclusion Criteria: - Women participating in other nutrition trials - Women who intend to leave the study area - Women who are already pregnant |
Country | Name | City | State |
---|---|---|---|
Pakistan | Matiari Research and Training Centre | Matiari | Sindh |
Lead Sponsor | Collaborator |
---|---|
Aga Khan University | Bill and Melinda Gates Foundation, National Program for Family Planning and Primary Health Care, The Hospital for Sick Children |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Anemia status | Hemoglobin concentration <12 g/dL | 0, 12*, 24 months (*in subgroup only) | |
Primary | Low birth weight | Birth weight <2500 g | At birth | |
Secondary | Biomarkers: serum ferritin, serum transferrin receptor, hepcidin, serum retinol, serum 25(OH)D, alpha-glycolytic protein, C-reactive protein (women) | Preconception (subgroup only): enrolment, 1 year, 2 years; Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week | ||
Secondary | Anthropometrics: height (women) | Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months | ||
Secondary | Anthropometrics: middle upper arm circumference (women) | Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months | ||
Secondary | Anthropometrics: weight (women) | Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months | ||
Secondary | Gestational age | At birth | ||
Secondary | Preterm birth | At birth | ||
Secondary | Stillbirth | At birth | ||
Secondary | Small for gestational age | At birth | ||
Secondary | Birth size: length | Within 24 hours of birth | ||
Secondary | Birth size: head circumference | Within 24 hours of birth | ||
Secondary | Birth size: middle upper arm circumference | Within 24 hours of birth | ||
Secondary | Birth size: weight | Within 24 hours of birth | ||
Secondary | Birth defects | At birth | ||
Secondary | Infant growth: length | 1, 3, 6, 9, 12 months | ||
Secondary | Infant growth: head circumference | 1, 3, 6, 9, 12 months | ||
Secondary | Infant growth: middle upper arm circumference | 1, 3, 6, 9, 12 months | ||
Secondary | Infant growth: weight | 1, 3, 6, 9, 12 months | ||
Secondary | Age at marriage | Enrolment, 1 year, 2 years | ||
Secondary | Completion of 10th grade education | Enrolment, 1 year, 2 years | ||
Secondary | Use of sanitary pad during last menstrual period | Enrolment, 1 year, 2 years | ||
Secondary | Dietary intake: 24-hour recall (subgroup of women) | Preconception: enrolment; Pregnancy: 4-12 weeks, 32 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Terminated |
NCT02537145 -
PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women
|